QUOTED. 15 July 2019. Christy Wyskiel.
Liquid biopsy technology is drawing increasing attention from regulators, big manufacturers and investors alike as recent developments in this field show. See what Johns Hopkins's head of technology ventures, Christy Wyskiel, said about it here.
“If this is truly like a cholesterol test, something that some portion of the population has every single year, year-in and year-out, that's tens of millions of tests per year.” – Christy Wyskiel, head of technology ventures, Johns Hopkins University
- Find out more: Breakthrough Status, Big Investments For Liquid Biopsies
Click here for a free trial of Medtech Insight